Residual solvent analysis of pharmaceutical products in accordance with the ICH Q3C guideline

Chemical analysis Résolution de problème R&D support
More than 140 people
More than 140 people at your service
5200 m² laboratory
5200 m² laboratory + 99% of services are provided in-house

Your needs: reliably analyze residual solvents in your pharmaceutical products to meet ICH Q3C requirements

What is ICH Q3C?

The ICH (International Conference on Harmonisation) Q3C guideline provides recommendations on toxicologically acceptable concentrations, for patient safety, of residual solvents (or volatile residual impurities) in pharmaceutical products.

Thus, the ICH Q3C guideline classifies residual solvents into three categories according to their toxicological risk to humans:

Class 1 residual solvents: avoid These are solvents that are carcinogenic (or suspected to be carcinogenic) in humans and pose a risk to the environment.
Class 2 residual solvents: limit These are solvents suspected of having other significant but reversible toxic effects.
Class 3 residual solvents: low toxic potential

What is a residual solvent according to ICH Q3C?

Residual solvents in pharmaceutical products are defined as volatile organic chemicals used or produced during the manufacture of pharmaceutical products or drug substances (benzene, acetone, cyclohexane, toluene, 1,4-dioxane, etc.).

Residual solvents provide no therapeutic benefits. However, an organic solvent may be used in pharmaceutical manufacturing to improve production yield, or to establish the physicochemical properties of a substance or pharmaceutical product (such as purity, crystallinity, or solubility).

Consequently, finding residual solvents in pharmaceutical products is not impossible, particularly because certain manufacturing techniques do not completely eliminate them.

How can residual solvents be identified and quantified in pharmaceutical products?

Residual solvents are usually isolated using separation techniques such as gas chromatography coupled with mass spectrometry (GC-MS). Wherever possible, harmonized methods described in pharmacopoeias (USP 467) should be used to determine residual solvent concentrations. Otherwise, the selected analytical method must undergo appropriate validation.

Validation of residual solvent analytical methods must comply with the guidelines set out in the ICH Q2 documents (USP 467).

Conducting regular checks helps prevent production incidents and ensures continued compliance with evolving pharmaceutical specifications.

Discover them all Our Accreditations – Client Qualifications

AIRBUS

Qualification

FILAB laboratory supports you in analyzing residual solvents in your pharmaceutical products in accordance with ICH Q3C

Our ICH Q3C solvent analysis services

For over 30 years, our FILAB laboratory has had the experience and dedicated analytical facilities to support pharmaceutical companies today with residual solvent analysis in accordance with the ICH Q3C guideline, through tailored support.

Working with a laboratory of experts in ICH Q3C solvent analysis, such as FILAB, makes it easier to understand the strategic challenges and changes affecting the pharmaceutical industry.

The FILAB laboratory supports pharmaceutical companies with pharmaceutical stability testing and the detection of residual solvents in pharmaceutical products and substances, using its GC-MS and HS-GC-MS equipment, along with expertise in pharmaceutical analysis. 

The filab advantages
A highly qualified team
A highly qualified team
Responsiveness in responding to and processing requests
Responsiveness in responding to and processing requests
A COFRAC ISO 17025 accredited laboratory
A COFRAC ISO 17025 accredited laboratory
(Staves available on www.cofrac.com - Accreditation number: 1-1793)
A complete analytical facility of 5,200m²
A complete analytical facility of 5,200m²
Tailor-made support
Tailor-made support
Video debriefing available with the expert
Video debriefing available with the expert
Anaïs DECAUX Customer Support Manager
Ask for your quote